DUX4 expression in FSHD muscle cells: how could such a rare protein cause a myopathy?-Reference-Cited by-同舟云学术

DUX4 expression in FSHD muscle cells: how could such a rare protein cause a myopathy?

Published:2012-12-04 Issue:1 Volume:17 Page:76-89
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J. Cell. Mol. Med.

Author:

Tassin Alexandra¹,Laoudj-Chenivesse Dalila²,Vanderplanck Céline¹,Barro Marietta²,Charron Sébastien¹,Ansseau Eugénie¹,Chen Yi-Wen³,Mercier Jacques²,Coppée Frédérique¹,Belayew Alexandra¹

Affiliation:

1. Laboratory of Molecular Biology; Research Institute for Health Sciences and Technology; University of Mons; Mons; Belgium

2. INSERM U1046 Physiologie et Médecine expérimentale Cœur et Muscle; CHU A. de Villeneuve; Montpellier; France

3. Children's National Medical Center; Center for Genetic Medicine Research; Washington; DC; USA

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1582-4934.2012.01647.x/fullpdf

Reference45 articles.

1. Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystrophy;Hewitt;Hum Mol Genet,1994

2. The FSHD-associated repeat, D4Z4, is a member of a dispersed family of homeobox-containing repeats, subsets of which are clustered on the short arms of the acrocentric chromosomes;Lyle;Genomics,1995

3. Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy;Wijmenga;Nat Genet,1992

4. Monosomy of distal 4q does not cause facioscapulohumeral muscular dystrophy;Tupler;J Med Genet,1996

5. Clinical features of facioscapulohumeral muscular dystrophy 2;Greef;Neurology,2010

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantifying anti-DUX4 therapy for facioscapulohumeral muscular dystrophy;2024-08-15

2. An open-label pilot study of losmapimod to evaluate the safety, tolerability, and changes in biomarker and clinical outcome assessments in participants with facioscapulohumeral muscular dystrophy type 1;Journal of the Neurological Sciences;2024-07

3. Systemic Pharmacotherapeutic Treatment of the ACTA1-MCM/FLExDUX4 Preclinical Mouse Model of FSHD;International Journal of Molecular Sciences;2024-06-26

4. Meta-analysis towards FSHD reveals misregulation of neuromuscular junction, nuclear envelope, and spliceosome;Communications Biology;2024-05-25

5. Developmental regulators drive DUX4 expression in facioscapulohumeral muscular dystrophy;2024-05-21